Genomics

Dataset Information

0

Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant Tamoxifen mono-therapy: a DBCG study


ABSTRACT: Purpose: Despite the benefits of estrogen receptor (ER)-targeted endocrine therapies in breast cancer, many tumors develop resistance. MicroRNAs (miRNAs) have been suggested as promising biomarkers and we here evaluated whether a miRNA profile could be identified, sub-grouping ER+ breast cancer patients treated with adjuvant Tamoxifen with regards to probability of recurrence. Experimental design: Global miRNA analysis was performed on 152 ER+ primary tumors from high-risk breast cancer patients with an initial discovery set of 52 patients, followed by 2 independent test sets (N=60 and N=40). All patients had received adjuvant Tamoxifen as mono-therapy (median clinical follow-up: 4.6 years) and half had developed distant recurrence (median time-to-recurrence: 3.5 years). MiRNA expression was examined by unsupervised hierarchical clustering and supervised analysis, including clinical parameters as co-variables.

ORGANISM(S): Betapolyomavirus hominis Human gammaherpesvirus 8 Human alphaherpesvirus 1 JC polyomavirus Murid gammaherpesvirus 4 Betapolyomavirus macacae human gammaherpesvirus 4 Homo sapiens Human immunodeficiency virus 1 Human betaherpesvirus 5 Murid betaherpesvirus 1

PROVIDER: GSE37405 | GEO | 2012/04/19

SECONDARY ACCESSION(S): PRJNA159897

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2011-07-08 | E-GEOD-22216 | biostudies-arrayexpress
2015-08-01 | E-GEOD-56411 | biostudies-arrayexpress
2015-08-01 | GSE56411 | GEO
2014-07-01 | E-GEOD-46823 | biostudies-arrayexpress
2014-07-01 | GSE46823 | GEO
2011-07-08 | E-GEOD-22219 | biostudies-arrayexpress
2004-06-07 | GSE1378 | GEO
2004-06-07 | GSE1379 | GEO
2011-07-08 | GSE22219 | GEO
2011-07-08 | GSE22216 | GEO